66 related articles for article (PubMed ID: 37306026)
1. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
3. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway.
Huang J; Yang J; Zhang Y; Lu D; Dai Y
Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332
[TBL] [Abstract][Full Text] [Related]
4. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract][Full Text] [Related]
5. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
6. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner.
Yin Z; Guo X; Liang X; Wang Z
Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer.
Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L
BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441
[TBL] [Abstract][Full Text] [Related]
8. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract][Full Text] [Related]
9. Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.
Zhang C; Xie L; Lin Z
Cell Biol Int; 2023 Dec; 47(12):1987-1998. PubMed ID: 37655555
[TBL] [Abstract][Full Text] [Related]
10. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m
Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K
Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553
[TBL] [Abstract][Full Text] [Related]
11. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
[TBL] [Abstract][Full Text] [Related]
12. FTO modifies the m6A level of MALAT and promotes bladder cancer progression.
Tao L; Mu X; Chen H; Jin D; Zhang R; Zhao Y; Fan J; Cao M; Zhou Z
Clin Transl Med; 2021 Feb; 11(2):e310. PubMed ID: 33634966
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of FTO inhibits excessive proliferation and promotes the apoptosis of human glomerular mesangial cells by alleviating FOXO6 m6A modification via YTHDF3-dependent mechanisms.
Zhuang X; Liu T; Wei L; Gao J
Front Pharmacol; 2023; 14():1260300. PubMed ID: 37822879
[No Abstract] [Full Text] [Related]
14. KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.
Zhang FY; Wu L; Zhang TN; Chen HH
Commun Biol; 2024 Mar; 7(1):262. PubMed ID: 38438714
[TBL] [Abstract][Full Text] [Related]
15. The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer.
Zhao Y; Hu X; Yu H; Sun H; Zhang L; Shao C
Research (Wash D C); 2024; 7():0313. PubMed ID: 38384328
[TBL] [Abstract][Full Text] [Related]
16. Qiteng Xiaozhuo granules medicated serum inhibits excessive proliferation and promotes apoptosis of human glomerular mesangial cells by targeting fat mass and obesity associated proteins.
Xingxing Z; Tao L; Liangbing W; Junmei S; Jiarong G
J Tradit Chin Med; 2023 Oct; 43(6):1072-1080. PubMed ID: 37946469
[TBL] [Abstract][Full Text] [Related]
17. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.
Li L; Zang L; Zhang F; Chen J; Shen H; Shu L; Liang F; Feng C; Chen D; Tao H; Xu T; Li Z; Kang Y; Wu H; Tang L; Zhang P; Jin P; Shu Q; Li X
Hum Mol Genet; 2017 Jul; 26(13):2398-2411. PubMed ID: 28398475
[TBL] [Abstract][Full Text] [Related]
18. ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2.
Zhang Y; Chen X; Chen H; Zhang Y
Crit Rev Immunol; 2023; 43(6):1-13. PubMed ID: 37943149
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of fat mass and obesity alleviates the ferroptosis in Parkinson's disease through m6A-NRF2-dependent manner.
Pang P; Zhang S; Fan X; Zhang S
Cell Biol Int; 2024 Apr; 48(4):431-439. PubMed ID: 38180302
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA GATA6-AS1 is mediated by N6-methyladenosine methylation and inhibits the proliferation and metastasis of gastric cancer.
Shen JJ; Li MC; Tian SQ; Chen WM
World J Gastrointest Oncol; 2024 Mar; 16(3):1019-1028. PubMed ID: 38577476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
